Catalyst Wire Dossier Catalyst Wire Dossier

BCG (Bacillus Calmette-Guérin)

Bacillus Calmette-Guérin
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BCG (Bacillus Calmette-Guérin), covering 2011-03-04 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer [Phase 3]

See pricing